Periodic Reporting for period 2 - IMMUNISA (A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer)

Cervical cancer (CxCa) is caused by high risk types of the human papillomavirus (a.o. HPV16). Prophylactic HPV vaccination is not the standard of care in all European countries, and where approved it is not sufficiently adopted. Once infected, these vaccines no longer prevent...